A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

White, Perrin; Ritzen, Martin; Oberfield, Sharon E.; Meyer-Bahlburg, Heino; Miller, Walter; Montori, Victor; Speiser, Phyllis; Azziz, Ricardo; Baskin, Laurence; Ghizzoni, Lucia; Hensle, Terry; Merke, Deborah

Steroid 21-hydroxylase deficiency accounts for about 95% of cases of congenital adrenal hyperplasia (CAH). Newborns are currently being screened for the classical forms of this disease throughout the United States and in 12 other countries. As such, it seems important to develop the best practice guidelines for treating not only infants and children, but affected adults as well. This report gives a brief overview of the most recent expert opinion and clinical practice guidelines for CAH as formulated by The Endocrine Society Task Force.



  • thumnail for 1687-9856-2010-494173.xml 1687-9856-2010-494173.xml application/xml 39.1 KB Download File
  • thumnail for application/zip 463 KB Download File

Also Published In

International Journal of Pediatric Endocrinology

More About This Work

Academic Units
BioMed Central
Published Here
September 8, 2014